BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26069105)

  • 1. Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma.
    Xie H; Xing C; Wei B; Xu X; Wu L; Wu J; Chen L; Cao G; Chen H; Meng X; Yin S; Zhou L; Zheng S
    Tumour Biol; 2015 Nov; 36(11):8881-6. PubMed ID: 26069105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma.
    Xie HY; Xing CY; Wei BJ; Xu X; Wu J; Chen LM; Cao GQ; Chen H; Chen KJ; Yin SY; Wu LM; Zhou L; Zheng SS
    Tissue Antigens; 2014 Sep; 84(3):264-70. PubMed ID: 24758241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
    Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
    Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX; Li SL; Yao YQ; Li TJ
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
    Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
    Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.
    Wu J; Zhang W; Xu A; Zhang L; Yan T; Li Z; Wu X; Zhu X; Ma J; Li K; Li H; Liu Y
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):595-600. PubMed ID: 23790025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
    Li G; Zheng Z
    Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
    Bose S; Tripathi DM; Sukriti ; Sakhuja P; Kazim SN; Sarin SK
    Gene; 2013 May; 519(2):231-7. PubMed ID: 23454624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.
    Shen N; Wang P; Li Y; Zhu Y; Gong Y; Zhong R; Lu Y; Cheng L
    Mol Carcinog; 2020 Aug; 59(8):980-988. PubMed ID: 32484301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B.
    Riazalhosseini B; Mohamed Z; Apalasamy YD; Eng HS; Mohamed R
    Pharmacogenet Genomics; 2016 Feb; 26(2):74-9. PubMed ID: 26529280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Necrosis Factor Alpha 308 G/A Single Nucleotide Polymorphism and Susceptibility to Hepatocellular Carcinoma Via Hepatitis B Infection.
    Azar SS; Mansoori M; Attar M; Shahbazi M
    Asian Pac J Cancer Prev; 2016; 17(7):3381-4. PubMed ID: 27509979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
    Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
    BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Wang L
    Infect Genet Evol; 2014 Oct; 27():77-82. PubMed ID: 25010264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.